fingolimod hydrochloride has been researched along with fluorodeoxyglucose f18 in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (fluorodeoxyglucose f18) | Trials (fluorodeoxyglucose f18) | Recent Studies (post-2010) (fluorodeoxyglucose f18) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 34,771 | 2,160 | 20,111 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coutinho, AM; de Andrade, DC; de Lima, LGCA; de Souza Godoy, LF; Pimentel, GA | 1 |
1 other study(ies) available for fingolimod hydrochloride and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Intense Hypermetabolic Tumefactive Demyelination on 18F-FDG PET and MRI Related to Multiple Sclerosis Relapse After Fingolimod Suspension.
Topics: Biopsy; Female; Fingolimod Hydrochloride; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Multiple Sclerosis; Myelin Sheath; Positron-Emission Tomography; Recurrence; Withholding Treatment | 2021 |